Abstract
Abstract Trichloroethylene (TCE) has been widely used as a degreasing agent in many manufacturing industries. Recently, the International Agency for Research on Cancer presented “sufficient evidence” for the causal relationship between TCE and kidney cancer. The aim of this study was to review the epidemiologic evidences regarding the relationship between TCE exposure and kidney cancer in Korean work environments. The results from the cohort studies were inconsistent, but according to the meta-analysis and case–control studies, an increased risk for kidney cancer was present in the exposure group and the dose–response relationship could be identified using various measures of exposure. In Korea, TCE is a commonly used chemical for cleaning or degreasing processes by various manufacturers; average exposure levels of TCE vary widely. When occupational physicians evaluate work-relatedness kidney cancers, they must consider past exposure levels, which could be very high (>100 ppm in some cases) and associated with jobs, such as plating, cleaning, or degreasing. The exposure levels at a manual job could be higher than an automated job. The peak level of TCE could also be considered an important exposure-related variable due to the possibility of carcinogenesis associated with high TCE doses. This review could be a comprehensive reference for assessing work-related TCE exposure and kidney cancer in Korea.
References
1. NIOSH. Special Occupational Hazard Review with Control Recommendations Trichloroethylene. U.S: Dept. of Health Education and Welfare Public Health Services;1978. p. 1–59.
2. Dekant W, Metzler M, Henschler D. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem Pharmaco. 1984; 33(13):2021–2027.
3. Guha N, Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Baan R, Mattock H, Straif K. International agency for research on cancer monograph working group. Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites. Lancet Oncol. 2012; 13(12):1192–1193.
6. McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer. 1988; 42:13–16.
7. Christensen PJ, Craig JP, Bibro MC, O'Connell KJ. Cysts containing renal cell carcinoma in von Hippel-Lindau diseases. J Urol. 1982; 128:798–800.
8. IARC. List of Classifications by Cancer Sites with Sufficient or Liited Evidence in Human, Volumes 1 to 109. http://monographs.iarc.fr/ENG/Classification/Table4.pdf.
9. Korea Occupational Safety and Health Agency. National working.
10. Cho HY, Cho SH, Ryoo JJ, Kim BG, Park S, Kang SK. A survey on the status of using trichloroethylene (TCE) in Korea. J Korean Soc Occup Environ Hyg. 2007; 17(3):254–260.
11. Paik NW, Choi YS, Meng KH. Trichloroethylene poisoning in degreasing process of an electric appliances manufacturing. Korean J Occup Health. 1970; 9(2):4–8.
12. Kim HA, Lee KM. Urinary excretion of total trichloro-compounds and air trichloroethylene concentration in trichloroethylene related workers. Korean J Occup Health. 1989; 28(1):9–13.
13. Kim CY, Cho CJ, Kim YH, Park DY, Paik NW, Kim HA, Lee KM. Trichloroethylene exposure of workers employed in degreasing process of metal manufacturing. Korean J Occup Health. 1989; 28(4):126–137.
14. Lee KH, Paik NW. A study on worker exposure to trichlorethylene and emission factor for degreasers in plating plants. J Korean Soc Occup Environ Hyg. 1993; 3(1):3–13.
15. Jeon HS, Kim HW. The relationship between airborne trichloroethylene concentrations and total trichloro – compounds and trichloroacetic acid in urine. J Korean Soc Occup Environ Hyg. 1994; 4(1):7–16.
16. Kang SK, Cho YS, Moon YH. Brain stem auditory evoked potential and R-R interval analysis of the workers exposed to trichloroethylene. Korean J Occup Environ Med. 1995; 7(1):111–119.
17. Scott CS, Jinot J. Trichloroethylene and cancer: systematic and quantitative review of epidemiologic evidence for identifying hazards. Int J Environ Res Public Health. 2011; 8:4238–4272.
18. Karami S, Lan Q, Rothman N, Stewart PA, Lee KM, Vermeulen R, Moore LE. Occupational trichloroethylene exposure and kidney cancer risk: a meta-analysis. Occup Environ Med. 2012; 69(12):858–867.
19. Bruckner JV, Anand SS, Warren DA. Toxic Effects of Solvents and Vapors. In The Basic Science of Poisons. InCasarett & Doull's Toxicology: Klaassen CD. McGrqw-Hill Education;2013. p. 1031–1130.
20. Zhao Y, Krishnadasan A, Kennedy N, Morgenstern H, Ritz B. Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers. Am J Ind Med. 2005; 48:249–258.
21. Raaschou-Nielsen O, Hansen J, McLaughlin JK, Kolstad H, Christensen JM, Tarone RE, Olsen JH. Cancer risk among workers at Danish companies using trichloroethylene: a cohort study. Am J Epidemiol. 2003; 158(12):1182–1192.
22. Morgan RW, Kelsh MA, Zhao K, Heringer S. Mortality of aerospace workers exposed to trichloroethylene. Epidemiology. 1998; 9:424–431.
23. Boice JD Jr, Marano DE, Cohen SS, Mumma MT, Blot WJ, Brill AB, Fryzek JP, Henderson BE, McLaughlin JK. Mortality among Rocketdyne workers who tested rocket engines, 1948–1999. J Occup Environ Med. 2006; 48:1070–1092.
24. Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Holcatova I, Merino M, Chanock S, Chow WH, Rothman N. Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res. 2010; 70:6527–6536.
25. Charbotel B, Fevotte J, Hours M, Martin JL, Bergeret A. Case– control study on renal cell cancer and occupational exposure to trichloroethylene. Part II: Epidemiological aspects. Ann Occup Hyg. 2006; 50:777–787.
26. Bruning T, Pesch B, Wiesenhutter B, Rabstein S, Lammert M, Baumuller A, Bolt HM. Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case–control study in Arnsberg, Germany. Am J Ind Med. 2003; 43(3):274–285.
Table 1
Total | Men | Women | ||||
---|---|---|---|---|---|---|
CR | ASR | CR | ASR | CR | ASR | |
1999 | 3.0 | 3.1 | 4.1 | 4.7 | 1.9 | 1.7 |
2000 | 3.0 | 3.0 | 4.1 | 4.6 | 1.9 | 1.8 |
2001 | 3.5 | 3.4 | 4.7 | 5.1 | 2.2 | 2.0 |
2002 | 3.6 | 3.5 | 5.0 | 5.2 | 2.3 | 2.1 |
2003 | 3.9 | 3.6 | 5.3 | 5.4 | 2.5 | 2.2 |
2004 | 4.3 | 3.9 | 5.8 | 5.7 | 2.8 | 2.4 |
2005 | 4.9 | 4.2 | 6.6 | 6.3 | 3.1 | 2.5 |
2006 | 5.4 | 4.6 | 7.4 | 6.8 | 3.5 | 2.7 |
2007 | 6.0 | 5.0 | 8.3 | 7.4 | 3.7 | 2.9 |
2008 | 6.6 | 5.2 | 9.0 | 7.8 | 4.1 | 3.1 |
2009 | 7.0 | 5.5 | 9.4 | 7.9 | 4.5 | 3.3 |
2010 | 7.3 | 5.5 | 10.1 | 8.3 | 4.3 | 3.1 |
2011 | 8.0 | 6.2 | 10.9 | 8.6 | 5.1 | 3.6 |
APC* | 6.2 | 2 (p<0.05) | 5.9 | 9 (p<0.05) | 6.3 | 3 (p<0.05) |